Cargando…

The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?

In patients with COVID-19, thromboinflammation is one of the main causes of morbidity and mortality, which makes anticoagulation an integral part of treatment. However, pharmacodynamic and pharmacokinetic properties of direct oral anticoagulants (DOACs) limit the use of this class of anticoagulants...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roguljić, Hrvoje, Arambašić, Jerko, Ninčević, Vjera, Kuna, Lucija, Šesto, Igor, Tabll, Ashraf, Smolić, Robert, Včev, Aleksandar, Primorac, Dragan, Wu, George Y., Smolić, Martina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Croatian Medical Schools 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284020/ https://www.ncbi.nlm.nih.gov/pubmed/35722697 http://dx.doi.org/10.3325/cmj.2022.63.287

Ejemplares similares

Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An Update
por: Roguljic, Hrvoje, et al.
Publicado: (2021)

Pretreatment of Garlic Oil Extracts Hampers Epithelial Damage in Cell Culture Model of Peptic Ulcer Disease
por: Kuna, Lucija, et al.
Publicado: (2022)

Renoprotective Effect of Liraglutide Is Mediated via the Inhibition of TGF-Beta 1 in an LLC-PK1 Cell Model of Diabetic Nephropathy
por: Ninčević, Vjera, et al.
Publicado: (2022)

Targeting the Wnt Signaling Pathway in Liver Fibrosis for Drug Options: An Update
por: Duspara, Kristina, et al.
Publicado: (2021)

Preclinical Models and Promising Pharmacotherapeutic Strategies in Liver Fibrosis: An Update
por: Kolaric, Tea Omanovic, et al.
Publicado: (2023)

Renal Benefits of SGLT 2 Inhibitors and GLP-1 Receptor Agonists: Evidence Supporting a Paradigm Shift in the Medical Management of Type 2 Diabetes
por: Ninčević, Vjera, et al.
Publicado: (2019)

Peptic Ulcer Disease: A Brief Review of Conventional Therapy and Herbal Treatment Options
por: Kuna, Lucija, et al.
Publicado: (2019)

Liraglutide Exerts Protective Effects by Downregulation of PPARγ, ACSL1 and SREBP-1c in Huh7 Cell Culture Models of Non-Alcoholic Steatosis and Drug-Induced Steatosis
por: Omanovic Kolaric, Tea, et al.
Publicado: (2022)

Molecular Mechanisms Linking Empagliflozin to Renal Protection in the LLC-PK1 Model of Diabetic Nephropathy
por: Mihaljević, Vjera, et al.
Publicado: (2022)

Risk Factors Contributing to the Occurrence and Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Patients Treated with Direct-Acting Antivirals
por: Kishta, Sara, et al.
Publicado: (2020)

Mechanisms of Hepatic Cholestatic Drug Injury
por: Kolarić, Tea Omanović, et al.
Publicado: (2019)

Obesity Paradox in Chronic Liver Diseases: Product of Bias or a Real Thing?
por: Curcic, Ines Bilic, et al.
Publicado: (2019)

Drug-induced Fatty Liver Disease: Pathogenesis and Treatment
por: Kolaric, Tea Omanovic, et al.
Publicado: (2021)

Antioxidant Pre-Treatment Reduces the Toxic Effects of Oxalate on Renal Epithelial Cells in a Cell Culture Model of Urolithiasis
por: Kizivat, Tomislav, et al.
Publicado: (2017)

Biomarkers for Assessing Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus on Sodium–Glucose Cotransporter 2 Inhibitor Therapy
por: Khaznadar, Farah, et al.
Publicado: (2023)

Representation of CYP3A4, CYP3A5 and UGT1A4 Polymorphisms within Croatian Breast Cancer Patients’ Population
por: Bojanic, Kristina, et al.
Publicado: (2020)

An Update on Efficacy and Safety of Emerging Hepatic Antifibrotic Agents
por: Rupcic Rubin, Vinka, et al.
Publicado: (2021)

Glycosylation Alterations in Cancer Cells, Prognostic Value of Glycan Biomarkers and Their Potential as Novel Therapeutic Targets in Breast Cancer
por: Peric, Luka, et al.
Publicado: (2022)

Mechanistic-Based Classification of Endocytosis-Related Inhibitors: Does It Aid in Assigning Drugs against SARS-CoV-2?
por: Hessien, Mohamed, et al.
Publicado: (2023)

MicroRNAs: Small Molecules with Significant Functions, Particularly in the Context of Viral Hepatitis B and C Infection
por: Megahed, Fayed, et al.
Publicado: (2023)

Association of Wnt Inhibitors, Bone Mineral Density and Lifestyle Parameters in Women with Breast Cancer Treated with Anastrozole Therapy
por: Bojanić, Kristina, et al.
Publicado: (2018)

Serotonin Receptor Agonists in the Treatment of Migraine: A Meta-Analysis Considering Possible Connection with Paresthesia
por: Katalinic, Darko, et al.
Publicado: (2022)

HCV Extrahepatic Manifestations
por: Kuna, Lucija, et al.
Publicado: (2019)

Therapeutic Perspectives of IL1 Family Members in Liver Diseases: An Update
por: Ćurčić, Ines Bilić, et al.
Publicado: (2022)

The Role of GLP1-RAs in Direct Modulation of Lipid Metabolism in Hepatic Tissue as Determined Using In Vitro Models of NAFLD
por: Petrovic, Ana, et al.
Publicado: (2023)

Primary Care Provider Counseling Practices about Adverse Drug Reactions and Interactions in Croatia
por: Raguz Lucic, Nikola, et al.
Publicado: (2018)

Molecular Mechanisms of Resistance to Immune Checkpoint Inhibitors in Melanoma Treatment: An Update
por: Vukadin, Sonja, et al.
Publicado: (2021)

The Correlation of Serum Calpain 1 Activity and Concentrations of Interleukin 33 in COVID-19 Acute Respiratory Distress Syndrome
por: Loinjak, Domagoj, et al.
Publicado: (2023)

The accuracy of breast cancer risk self-assessment does not correlate with knowledge about breast cancer and knowledge and attitudes towards primary chemoprevention
por: Bojanic, Kristina, et al.
Publicado: (2020)

Hypothyroidism and Nonalcoholic Fatty Liver Disease: Pathophysiological Associations and Therapeutic Implications
por: Kizivat, Tomislav, et al.
Publicado: (2020)

Noninvasive Fibrosis Assessment in Chronic Hepatitis C Infection: An Update
por: Bojanic, Kristina, et al.
Publicado: (2023)

Models of Drug Induced Liver Injury (DILI) – Current Issues and Future Perspectives
por: Kuna, Lucija, et al.
Publicado: (2018)

LIFESTYLE RISK FACTORS AND BONE MASS IN RECURRENT STONE-FORMING PATIENTS: A CROSS-SECTIONAL STUDY IN 144 SUBJECTS
por: Marić, Ivana, et al.
Publicado: (2019)

Management of Glycemia during Acute Aerobic and Resistance Training in Patients with Diabetes Type 1: A Croatian Pilot Study
por: Ivandic, Marul, et al.
Publicado: (2023)

Biomarkers for Hepatocellular Carcinoma: From Origin to Clinical Diagnosis
por: Omar, Mona A., et al.
Publicado: (2023)

Pharmacogenetics of Anticoagulants
por: Rane, Anders, et al.
Publicado: (2010)

Osteopontin Levels in Patients with Squamous Metastatic Head and Neck Cancer
por: Maleš, Josip, et al.
Publicado: (2021)

Population study of thrombophilic markers and pharmacogenetic markers of warfarin prevalence in Bosnia and Herzegovina
por: Ašić, Adna, et al.
Publicado: (2019)

Pharmacogenetics aspects of oral anticoagulants therapy
por: Militaru, FC, et al.
Publicado: (2015)

Update on the Development of Anti-Viral Agents Against Hepatitis C
por: Macarthur, Kristin L., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_uaidfbhapsd1h2gr46rh0oh6v6